Efficacy of bendamustine on thrombocytopenia and hemolytic anemia secondary to CD5‑positive B‑cell lymphoma with massive splenomegaly in a patient with rheumatoid arthritis

  • Authors:
    • Yuzuru Hosoda
    • Hiroshi Hagino
    • Norihiko Hino
    • Toru Motokura
  • View Affiliations

  • Published online on: September 19, 2017     https://doi.org/10.3892/mco.2017.1425
  • Pages: 855-858
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Chemotherapy for lymphoma may be avoided in the presence of coincident cytopenia. In case of immune cytopenia secondary to lymphoma, treatment of cytopenia is the same for primary cases, however, chemotherapy for lymphoma may be effective at the cost of severe hematological toxicity. The present study reports a complex case of thrombocytopenia and direct antiglobulin test‑negative hemolytic anemia, thus mimicking Evans syndrome, secondary to cluster of differentiation 5‑positive B‑cell lymphoma with massive splenomegaly, in a patient suffering from rheumatoid arthritis for two decades. Treatment with prednisolone, high‑dose dexamethasone, eltrombopag and rituximab for cytopenia were not effective. Chemotherapy with bendamustine subsequently resolved the cytopenia, additionally resulting in a complete remission of lymphoma. Thus, bendamustine may have a role in the management of lymphoma complicated with severe cytopenia.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 7 Issue 5

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hosoda Y, Hagino H, Hino N and Motokura T: Efficacy of bendamustine on thrombocytopenia and hemolytic anemia secondary to CD5‑positive B‑cell lymphoma with massive splenomegaly in a patient with rheumatoid arthritis. Mol Clin Oncol 7: 855-858, 2017
APA
Hosoda, Y., Hagino, H., Hino, N., & Motokura, T. (2017). Efficacy of bendamustine on thrombocytopenia and hemolytic anemia secondary to CD5‑positive B‑cell lymphoma with massive splenomegaly in a patient with rheumatoid arthritis. Molecular and Clinical Oncology, 7, 855-858. https://doi.org/10.3892/mco.2017.1425
MLA
Hosoda, Y., Hagino, H., Hino, N., Motokura, T."Efficacy of bendamustine on thrombocytopenia and hemolytic anemia secondary to CD5‑positive B‑cell lymphoma with massive splenomegaly in a patient with rheumatoid arthritis". Molecular and Clinical Oncology 7.5 (2017): 855-858.
Chicago
Hosoda, Y., Hagino, H., Hino, N., Motokura, T."Efficacy of bendamustine on thrombocytopenia and hemolytic anemia secondary to CD5‑positive B‑cell lymphoma with massive splenomegaly in a patient with rheumatoid arthritis". Molecular and Clinical Oncology 7, no. 5 (2017): 855-858. https://doi.org/10.3892/mco.2017.1425